View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Christer Magnergård ... (+20)
  • Christer Magnergård
  • Eivind Sars Veddeng
  • Frank Maaø
  • Helge André Martinsen
  • Jesper Ingildsen
  • Jon Masdal
  • Marius Knudssøn
  • Martin Arnell
  • Martin Huseby Karlsen
  • Mattias Holmberg
  • Mattias Montgomery
  • Niclas Gehin
  • Nicolas McBeath
  • Nicolay Dyvik
  • Ole Martin Westgaard
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Rune Majlund Dahl
  • Simen Mortensen
  • Stefan Gauffin
Rune Majlund Dahl
  • Rune Majlund Dahl

Novozymes (Sell, TP: DKK280.00) -

Novozymes (NZYMB DC, Sell) - (16 pages)

Rune Majlund Dahl
  • Rune Majlund Dahl

Novozymes (Sell, TP: DKK280.00) - Slow start to the year

Novozymes (NZYMB DC, Sell) - Slow start to the year (10 pages)

Christoffer Wang Bjørnsen ... (+11)
  • Christoffer Wang Bjørnsen
  • Håkon Astrup
  • Jon Masdal
  • Karl-Johan Bonnevier
  • Mattias Holmberg
  • Niclas Gehin
  • Nicolay Dyvik
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Rune Majlund Dahl
  • Simen Mortensen
Rune Majlund Dahl
  • Rune Majlund Dahl

Novozymes (Sell, TP: DKK280.00) - We expect weak start to the year

The Q1 results are due at 08:00 CET on 25 April. We forecast low organic growth of 3.4% for Q1, hampered by continued pressure on some large customers in Household Care, while Agriculture & Feed is also set to be backend-loaded. Our Q1 EBIT margin of 27.7% (down 1.3%-points to adj. EBIT margin YOY) reflects our forecasts for negative FX effects, increased investments and lower deferred income. We reiterate our DKK280 target price and SELL recommendation.

Alexander Aukner ... (+11)
  • Alexander Aukner
  • Antti Kansanen
  • Eivind Sars Veddeng
  • Håkon Astrup
  • Helge André Martinsen
  • Mattias Holmberg
  • Niclas Gehin
  • Nicolas McBeath
  • Ole-Andreas Krohn
  • Rune Majlund Dahl
  • Stefan Gauffin
Rune Majlund Dahl
  • Rune Majlund Dahl

Novozymes (Sell, TP: DKK280.00) -

Novozymes (NZYMB DC, Sell) - (15 pages)

Rune Majlund Dahl
  • Rune Majlund Dahl

Novozymes (Sell, TP: DKK290.00) -

Novozymes (NZYMB DC, Sell) - (10 pages)

Rune Majlund Dahl
  • Rune Majlund Dahl

Q2: Top and bottom line miss

Novozymes (NZYMB DC, Sell) - (10 pages)

Rune Majlund Dahl
  • Rune Majlund Dahl

HouseholdCare and BioAg in focus

Novozymes (NZYMB DC, Sell) - (16 pages)

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch